Capsid-directed Immunity
Capsid-Directed Immunity is an immune response category characterized by the targeting of viral capsid proteins by humoral and/or cellular immune mechanisms following gene therapy administration, distinguishing it from transgene-directed immunity by focusing on vector-encoded structural components rather than the therapeutic transgene product.
60
Publications
3.1K
Citations
394
Authors
129
Institutions
Publications per year
2017–2026
9
60
Hanne Gahéry‐Ségard, Françoise Farace, Dominique Godfrin et al. · Journal of Virology · 1998 · 212 citations · Full text
Life Sciences, Immunology, Oncology +15
1–5 of 60
394
4
h-index
3
h-index
3
h-index
3
h-index
2
h-index
1–5 of 394
129
University of Pennsylvania
Philadelphia, United States
5 h-index
24 publications
3.7K citations

Howard Hughes Medical Institute
Chevy Chase, United States
4 h-index
6 publications
835 citations

Children's Hospital of Philadelphia
Philadelphia, United States
4 h-index
27 publications
3.1K citations
Inserm
Paris, France
3 h-index
17 publications
1.6K citations
Centro de Ingeniería Genética y Biotecnología
Havana, Cuba
3 h-index
26 publications
1.4K citations
Instituto de Medicina Tropical “Pedro Kourí”
Havana, Cuba
3 h-index
6 publications
305 citations
Charles University
Prague, Czechia
2 h-index
7 publications
137 citations
German Cancer Research Center
Heidelberg, Germany
2 h-index
8 publications
150 citations
1–8 of 129
13 publications · 401 citations
13
h-index
6 publications · 500 citations
6
h-index
JVI · 6 publications · 419 citations
6
h-index
3 publications · 82 citations
3
h-index
2 publications · 41 citations
2
h-index
1–5